John W. Frew

Approved Monoclonal Antibody Therapies for Hidradenitis Suppurativa

Importance Biologic therapies are increasingly used for moderate to severe hidradenitis suppurativa (HS), yet their high cost presents challenges for health systems and payers. Comparative economic evaluations of these therapies are limited. Objective To evaluate the efficiency f...